Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2011
02/03/2011WO2011014278A1 Proteases with modified pre-pro regions
02/03/2011WO2010144698A3 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
02/03/2011WO2010144336A3 Methods for treating chronic kidney disease
02/03/2011WO2010141724A3 Peptide dicer substrate agents and methods for their specific inhibition of gene expression
02/03/2011US20110030106 Brassica plant comprising a mutant indehiscent allele
02/03/2011US20110030104 Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof
02/03/2011US20110030098 Glycosyltransferases, Polynucleotides Encoding These And Methods Of Use
02/03/2011US20110030096 AXMI-192 Family of Pesticidal Genes and Methods for Their Use
02/03/2011US20110030094 Nucleic Acid Sequences Encoding Proteins Associated with Abiotic Stress Response and Plant Cells with Increased Tolerance to Environmental Stress
02/03/2011US20110030093 Brittle stalk 2 gene family and related methods and uses
02/03/2011US20110030092 Promoter, promoter control elements, and combinations, and uses thereof
02/03/2011US20110030091 Grg23 epsp synthases: compositions and methods of use
02/03/2011US20110030090 Disease resistance genes
02/03/2011US20110030086 Corn event das-59122-7 and methods for detection thereof
02/03/2011US20110030075 Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner
02/03/2011US20110028704 Nucleic acid sequences encoding invertase proteins
02/03/2011US20110028692 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners
02/03/2011US20110028691 Recombinant toxin fragments
02/03/2011US20110028689 Nucleic acids that encode sodium channel
02/03/2011US20110028686 Protein binding miniature proteins
02/03/2011US20110028685 Analyte Determination Utilizing Mass Tagging Reagents Comprising A Non-Encoded Detectable Label
02/03/2011US20110028537 Somatic cell reprogramming
02/03/2011US20110028533 Novel fer -like protein, pharmaceutical compositions containing it and method for its use
02/03/2011US20110028531 Novel sirna compounds for inhibiting rtp801
02/03/2011US20110028498 Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase
02/03/2011US20110028423 Agent that modulates physiological condition of pests, involved in insect choline acetyltransferase activity
02/03/2011US20110028403 HSP70-Based Treatment for Autoimmune Diseases and Cancer
02/03/2011US20110028395 Peptide modulators of angiogenesis and use thereof
02/03/2011US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
02/03/2011US20110028378 Protease Variants and Compositions
02/03/2011US20110028375 Fungal serine protease and use thereof
02/03/2011US20110028348 Binding polypeptides with optimized scaffolds
02/03/2011US20110028338 Signatures of radiation response
02/03/2011US20110028332 Marker for diagnosis of breast cancer, test method, and test kit
02/03/2011US20110027907 Ssl7 mutants and uses therefor
02/03/2011US20110027890 Material for cell culture
02/03/2011US20110027883 Rna interference mediating small rna molecules
02/03/2011US20110027865 Everninomicin biosynthetic genes
02/03/2011US20110027862 Sample stabilization
02/03/2011US20110027861 Desiccated Biologics And Methods Of Preparing The Same
02/03/2011US20110027860 Gene encoding chondroitinase abc and uses therefor
02/03/2011US20110027859 Method for producing aminopeptidase
02/03/2011US20110027851 Compositions, methods and uses for biosynthetic plasmid integrated capture elements
02/03/2011US20110027834 Carry-Over Protection in Enzyme-Based Dna Amplification Systems Targeting Methylation Analysis
02/03/2011US20110027833 Thermostable type-a dna polymerase mutants with increased polymerization rate and resistance to inhibitors
02/03/2011US20110027830 Use of an aspartic protease (ns24) signal sequence for heterologous protein expression
02/03/2011US20110027829 Methods and Compositions
02/03/2011US20110027810 Chimeric recombinant antigens of toxoplasma gondii
02/03/2011US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
02/03/2011US20110027798 Hybridization Quantitation Method for Modified Micro-RNA and -DNA Based Oligonucleotides
02/03/2011US20110027797 Method for the Diagnosis of Higher- and Lower-Grade Astrocytoma Using Biomarkers and Diagnostic Kit Thereof
02/03/2011US20110027796 Method for detecting lung cancer using lung cancer-specific methylation marker gene
02/03/2011US20110027790 Methods of equalizing representation levels of nucleic acid targets
02/03/2011US20110027789 Methods for preservation of genomic dna sequence complexity
02/03/2011US20110027786 Primers for nucleic acid extension or amplification reactions
02/03/2011US20110027784 Novel Primers for Identification of Astrocytoma, Its Grades and Glioblastoma Prognosis
02/03/2011US20110027783 EXO1 Promotor Polymorphism Associated with Exceptional Life Expectancy in Humans
02/03/2011US20110027782 Probes and methods for detection of pathogens and antibiotic resistance
02/03/2011US20110027779 Polynucleotide primers
02/03/2011US20110027771 Methods and compositions for cell stabilization
02/03/2011US20110027414 Mutant ilv5 gene and use thereof
02/03/2011US20110027346 Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them
02/03/2011US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
02/03/2011US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods
02/03/2011US20110027304 Yersinia pestis antigens, vaccine compositions and related methods
02/03/2011US20110027300 Identification of a novel cysteine-rich cell penetrating peptide
02/03/2011US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods
02/03/2011US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
02/03/2011US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
02/03/2011US20110027287 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
02/03/2011US20110027282 Interferon antagonists, antibodies thereto and associated methods of use
02/03/2011US20110027277 Predictive marker for topoisomerase i inhibitors
02/03/2011US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
02/03/2011US20110027268 Anti-mesothelin antibodies and uses thereof
02/03/2011US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
02/03/2011US20110027266 Humanized anti-CXCR5 antibodies, derivatives thereof and their use
02/03/2011US20110027258 Modified vitamin k-dependent polypeptides
02/03/2011US20110027256 Fusion proteins
02/03/2011US20110027253 Padlock probe amplification methods
02/03/2011US20110027252 Variants of An Alpha-Amylase with Improved Production Levels in Fermentation Processes
02/03/2011US20110027249 Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens
02/03/2011US20110027248 Sugar Chain-Related Gene and Use Thereof
02/03/2011US20110027218 Tnf superfamily fusion proteins
02/03/2011US20110027187 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
02/03/2011US20110027173 Ephrin type-a receptor 10 protein
02/03/2011US20110023356 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt5 polypeptides and homologs thereof
02/03/2011CA2769670A1 Rna with a combination of unmodified and modified nucleotides for protein expression
02/03/2011CA2769420A1 Proteases with modified pre-pro regions
02/02/2011EP2280083A1 Nucleid acid ligand diagnostic biochip
02/02/2011EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours
02/02/2011EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
02/02/2011EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals
02/02/2011EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
02/02/2011EP2280019A1 Antisense modulation of C-reactive protein expression
02/02/2011EP2279194A1 Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use
02/02/2011CN201729886U Novel recovery device for recovering DNA in gel
02/02/2011CN1970573B Neutrality monoclonal antibody 3E1 for resisting ricin, its preparation method and uses
02/02/2011CN1863915B Lambda integrase mediated recombination in plants
02/02/2011CN1844387B Antisense oligonucleotide structure inhibiting Sirt1 gene expression and use thereof
02/02/2011CN101469327B ITS sequence specific to Klebsiella pneumoniae pneumonia or subsp.ozaenae and use